1. Home
  2. Health
  3. Back & Neck Pain

Cox-2 Inhibitors

By , About.com Guide

About.com Health's Disease and Condition content is reviewed by our Medical Review Board

Definition: Until the late 1990s, the big concern with NSAIDs was their possible toxic effect on the GI tract. NSAIDs have also been associated with kidney problems.

In the late 1990s, Cox-2 inhibitors, a newer NSAID, were introduced to provide an analgesic effect for moderate to severe musculoskeletal pain, without the side effects on the GI tract. In 2004, two Cox-2 inhibiting drugs were pulled off the market due to the identification of probable lethal side effects affecting the cardiovascular system.

Cox-2 inhibitors have been used for pain relief and to reduce inflammation. Cox-2 inhibitors have approximately the same pain relieving effects as the older NSAIDs.

In 2004, a study in Spine Journal reported that around 10% of all prescriptions issued were for Cox-2 inhibitors. Currently there is no official standard of care for alternatives to Cox-2 inhibitors.


Bibliography

1 Luo, X, Pietrobon, R, Curtis, L.H., Hey, L.A. Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States. Spine. 2004 Dec. 1.

2 Schnitzer TJ, Ferraro A, Hunsche E, Kong SX. A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain.. J Pain Symptom Manage July 2004.

Also Known As: newer NSAIDS newer nonsteroidal anti-inflammatory pain medication Vioxx Celebrex Bextra
Explore Back & Neck Pain
About.com Special Features

8 Ways to Cut Drug Costs

Learn how to save money on medications with these recommendations. More >

Healthy Bodies, Healthy Minds

Keep yourself, and your family, happy and healthy this fall with these tips. More >

We comply with the HONcode standard for trustworthy health information: verify here.
  1. Home
  2. Health
  3. Back & Neck Pain
  4. Chronic Back - Neck Pain
  5. Glossary
  6. C
  7. Cox-2 Inhibitors>

©2009 About.com, a part of The New York Times Company.

All rights reserved.